EUVIMEDEUVIMED entdecken
Crossref

Awareness of Partial Loss is Essential in Interpreting Merlin Immunohistochemistry When Diagnosing Pleural Mesothelioma

Kazuki Nabeshima iD, Tomomi Furukawa iD, Makoto Hamasaki iD, Kei Kushitani iD, Yukio Takeshima iD, Shigeki Shimizu, Kenzo Hiroshima iD, Maiko Takeda iD, Hironori Ninomiya iD, Katsumi Takizawa, Yuko Goto, Makiko Adachi iD

Pathology International · 2026-10 · 76 (10)

DOI: 10.1111/pin.70195 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathology International, online erschienen am 16.10.2026. Verfasst von Kazuki Nabeshima und 11 weiteren Autor:innen. Beteiligte Einrichtung: Fukuoka Tokushukai Hospital, Department of Diagnostic Pathology, Pathological Diagnosis Center, Fukuoka, Japan. Hauptthemen laut MEDLINE: Neurofibromin 2, Mesothelioma, Pleural Neoplasms, Biomarkers, Tumor. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Ministry of the Environment, Government of Japan, Ministry of the Environment.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ancillary assays, including BAP1 (BRCA‐1‐associated protein 1), MTAP (methylthioadenosine phosphorylase), and Merlin immunohistochemistry (IHC), are effective in discriminating pleural mesothelioma (PM) from reactive mesothelial proliferations (RMP). IHC of Merlin, a protein product of the neurofibromin 2 gene, was most recently developed. Our previous study suggested uneven occurrence of Merlin loss within PM tissues. This was further investigated here in a total of 41 tissues of PM obtained from seven institutions. Partial or diffuse Merlin loss was detected with excellent interobserver agreement (kappa: 0.82). Of the 34 PM cases with interobserver consensus, partial and diffuse loss of Merlin expression were each observed in 13 cases (38%). PM with partial Merlin loss exhibited either discrete or intermingled spatial distribution of Merlin‐lost cells. BAP1 or MTAP showed partial loss in none or only 5% of PM cases, respectively. The diagnostic sensitivity for PM was enhanced to 91% with addition of diffuse and partial Merlin loss to a combination of BAP1 and MTAP loss while maintaining 100% specificity. Although detection of Merlin loss as well as BAP1 and MTAP losses is effective for distinguishing PM from RMP, pathologists should be familiar with partial Merlin loss when interpreting Merlin IHC results.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurofibromin 2MesotheliomaPleural NeoplasmsBiomarkers, TumorLung NeoplasmsHumansImmunohistochemistryUbiquitin ThiolesteraseFemaleTumor Suppressor ProteinsMaleMesothelioma, MalignantMiddle AgedAgedDiagnosis, DifferentialAged, 80 and overPurine-Nucleoside PhosphorylaseAdultSensitivity and Specificity

Stichwörter der Autor:innen

BAP1CDKN2AFISHMTAPMerlinNF2immunohistochemistrypleural mesothelioma

Substanzen

Neurofibromin 2Biomarkers, TumorUbiquitin ThiolesteraseTumor Suppressor ProteinsBAP1 protein, humanPurine-Nucleoside Phosphorylase5'-methylthioadenosine phosphorylase

Autor:innen und Institutionen

  • Fukuoka Tokushukai Hospital, Department of Diagnostic Pathology, Pathological Diagnosis Center, Fukuoka, Japan.
  • Department of Pathology, Fukuoka University School of Medicine and Hospital, Fukuoka, Japan.
  • Department of Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Department of Laboratory Medicine and Pathology, National Hospital Organization Kinki-chuo Chest Medical Center, Osaka, Japan.
  • Department of Pathology, Tokyo Women's Medical University Yachiyo Medical Center, Yachiyo, Japan.
  • Department of Diagnostic Pathology, Nara Medical University School of Medicine, Nara, Japan.

ORCID-Profile: Kazuki Nabeshima, Tomomi Furukawa, Makoto Hamasaki, Kei Kushitani, Yukio Takeshima, Kenzo Hiroshima, Maiko Takeda, Hironori Ninomiya, Makiko Adachi

Förderung

  • Ministry of the Environment, Government of Japan
  • Ministry of the Environment

Zitieren

APA

Nabeshima, K., Furukawa, T., Hamasaki, M., Kushitani, K., Takeshima, Y., Shimizu, S., Hiroshima, K., Takeda, M., Ninomiya, H., Takizawa, K., Goto, Y., & Adachi, M. (2026). Awareness of Partial Loss is Essential in Interpreting Merlin Immunohistochemistry When Diagnosing Pleural Mesothelioma. Pathology International, 76(10). https://doi.org/10.1111/pin.70195

Vancouver

Nabeshima K, Furukawa T, Hamasaki M, Kushitani K, Takeshima Y, Shimizu S, et al. Awareness of Partial Loss is Essential in Interpreting Merlin Immunohistochemistry When Diagnosing Pleural Mesothelioma. Pathology International. 2026;76(10). doi:10.1111/pin.70195

BibTeX
@article{Nabeshima2026,
  author = {Nabeshima, Kazuki and Furukawa, Tomomi and Hamasaki, Makoto and Kushitani, Kei and Takeshima, Yukio and Shimizu, Shigeki and Hiroshima, Kenzo and Takeda, Maiko and Ninomiya, Hironori and Takizawa, Katsumi and Goto, Yuko and Adachi, Makiko},
  title = {Awareness of Partial Loss is Essential in Interpreting Merlin Immunohistochemistry When Diagnosing Pleural Mesothelioma},
  journal = {Pathology International},
  year = {2026},
  volume = {76},
  number = {10},
  doi = {10.1111/pin.70195}
}
Kostenlos starten →